Pharmacokinetics Services Market to Reach $6.7 Billion, Globally, by 2033 at 7.1% CAGR: The Brainy Insights


Pharmacokinetics services market size from USD 3.4 billion in 2023 to USD 6.7 billion in 10 years. Growing drug development activities will drive the market’s growth. North America emerged as the largest global pharmacokinetics services market, with a 37.2% market revenue share in 2023.

Newark, June 18, 2024 (GLOBE NEWSWIRE) — The Brainy Insights estimates that the USD 3.4 billion pharmacokinetics services market will reach USD 6.7 billion by 2033. To address the safety implications of the drug candidate, regulatory standards for clinical pharmacokinetic data have gradually changed in recent years. The first dosage that can be used to investigate the drug’s therapeutic effectiveness and any side effects is determined via a PK study. This element has drastically altered the structure of this market. Preclinical research has given way to speedy and efficient in-man investigations, including PK/PD analysis, in developing new drugs. It has been demonstrated that pharmacokinetic variability can be examined using humans in vivo and in vitro models during the clinical development stage of different drugs. The initial opportunity in drug development to assess the PK of medication is through phase I research. They are conducted on healthy volunteers or cancer patients to determine a safe and acceptable dose for the next stages of clinical trials. Several companies have expanded their service offerings to stay competitive in the market in response to the steady transition from drug development to sound pharmacology. This is demonstrated by the abundance of businesses offering a wide range of services to support different stages of pharmaceutical development.

Get more insights from the 230-page market research report @


Key Insights on Pharmacokinetics Services Market

North America will account for the largest market size during the forecast period.

North America dominated the Pharmacokinetics Services Market owing to the presence of prominent market players in the region. Prominent American pharmaceutical companies have established multiple strategic alliances with CROs offering PK investigation services in the region. The effective regulatory framework for drug development processes, which encompasses PKPD and toxicology research in the field, is primarily responsible for North America’s dominance.

The small molecules segment dominated the market with the most significant revenue of USD 2.00 billion.

The small molecules segment dominated the market with the most significant revenue of USD 2.00 billion. High market penetration and a growing generics market drive the growth of the molecules drug market. In addition, the drugs’ small size facilitates easy passage through the digestive tract, allowing the active ingredients to be rapidly absorbed into the bloodstream and distributed throughout the body.

The small and medium enterprise segment dominated the market with the most significant revenue of USD 1.90 billion.

The small and medium enterprise segment dominated the market, with the most significant revenue of USD 1.90 billion. There is increasing financial support from the government, and the flexibility of small and medium enterprises to take risks to satisfy customer requests and implement new technology have all contributed to the segment’s growth.

Custom Requirements can be requested for this report @

Market Dynamics:

Drivers: Growing drug development activities

The pharmaceutical industry invests heavily in drug discovery and development to address unmet medical needs and capitalise on commercial opportunities. Pharmacokinetic studies are crucial in assessing a drug’s absorption, distribution, metabolism, and excretion (ADME), which aids in optimising drug candidates and providing safe medication.

Restraint: High cost of services

Pharmacokinetics studies are expensive since they require certain equipment, expertise, and funding. Because of their high cost, smaller biotech companies or academic researchers with limited resources may be deterred from employing PK services.

Some of the major players operating in the pharmacokinetics services market are:

● Certara, L.P.
● GVK Biosciences Private Limited
● Pharmaceutical Product Development, LLC
● PAREXEL International Corporation
● Frontage Labs
● LGC Limited
● Evotec AG
● Shanghai Medicilon Inc.
● Charles River Laboratories International, Inc.
● Creative Bioarray

Key Segments cover in the market:

By Drug Type:

● Large Molecules
● Small Molecules

By Application:

● Large Enterprise
● Small And Medium Enterprise

Have a question? Speak to Research Analyst @

About the report:

The global pharmacokinetics services market is analyzed based on value (USD billion). All the segments have been analyzed on a worldwide, regional, and country basis. The study includes the analysis of more than 30 countries for each part. The report offers an in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining critical insight into the market. The study includes Porter’s five forces model, attractiveness analysis, raw material analysis, supply, and demand analysis, competitor position grid analysis, distribution, and marketing channels analysis.

About The Brainy Insights:

The Brainy Insights is a market research company, aimed at providing actionable insights through data analytics to companies to improve their business acumen. We have a robust forecasting and estimation model to meet the clients’ objectives of high-quality output within a short span of time. We provide both customized (clients’ specific) and syndicate reports. Our repository of syndicate reports is diverse across all the categories and sub-categories across domains. Our customized solutions are tailored to meet the clients’ requirements whether they are looking to expand or planning to launch a new product in the global market.

Contact Us

Avinash D
Head of Business Development
Phone: +1-315-215-1633
Email: [email protected] 

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.